Effects of SSMC With and Without Myofascial Release in Patients With Sciatica
Launched by RIPHAH INTERNATIONAL UNIVERSITY · Nov 18, 2024
Trial Information
Current as of July 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how two different types of treatment can help people with sciatica, a condition that causes pain that travels from the lower back down through the legs. The researchers want to find out if combining sensorimotor control training with a technique called myofascial release (which involves gentle stretching and manipulation of the muscles and tissues) is more effective than sensorimotor training alone. Participants will be divided into two groups: one will receive the training along with myofascial release, while the other will get just the training. Both groups will attend sessions three times a week for 12 weeks.
To join the study, participants should be diagnosed with sciatica, have ongoing pain in one leg for at least three months, and have a certain level of disability affecting their daily life. Some important things to note are that individuals who have had recent surgery on their spine, are participating in another trial, or have serious health conditions may not be eligible. This trial aims to help improve pain and mobility for those suffering from sciatica, and participants will receive professional care throughout the study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient Diagnosed with sciatica (confirmed by clinical examination and imaging)
- • Patient with Unilateral sciatica pain
- • Patient Experiencing symptoms for at least 3 months
- • Pain (VAS) score ≥ 5) in the lumbar and/or lower extremity region in patients.
- • The disability with a score of at least 20% by the Oswestry Disability Index (
- • Stable patient , no recent changes in treatment regimen for sciatica within the past 4 weeks
- Exclusion Criteria:
- • Patients with Lumbar spine surgery history within the past 6 months (11)
- • Patients who have been Another clinical trial participant within the past 3 months (1).
- • Patients with Physical therapy interventions contraindicated like in Severe cardiovascular disease and Uncontrolled hypertension Acute disc herniation requiring urgent surgical intervention (10).
- • Patients with Significant comorbidities like malignancy, spinal infection and Severe osteoporosis affecting spine stability (14).
- • Inability in patients to communicate effectively in Urdu or English, hindering comprehension of study instructions and assessments.
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lahore, Punjab, Pakistan
Patients applied
Trial Officials
Aruba Saeed, Phd
Principal Investigator
Riphah International University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported